Computer modeling is based on molecular dynamics (MD) conformational of opioid peptides in solution. Visualization permits inferences to be drawn on changes in the dihedrals in the backbone, chirality and side-chain of the constituent residues with direct impact on peptide binding. Knowledge gained from understanding the mechanisms of these interactions are essential for a rational approach to designing new peptides with agonist and antagonist activity. Modeling used various programs, such as MacroModel, Spartan, Hyperchem and AMBER, PC-based and Unix systems (Silicon Graphics). MD simulations on the 3 natural deltorphins indicated a relationship between delta affinity and conformation: deltorphin B is a more compact than deltorphins C or A with the latter two being more extended; all peptides exhibit -turns in their N-termini. D-Asp4 and Pro4 alter chirality and backbone conformation and modified the spatial conformation to resemble deltorphin B and enabled interaction with the same subset of delta opioid receptors. Length of the side-chain at position 4 affects intramolecular H bonding and accounts for differences in conformation. Simulated annealing indicated that peptides with -turns possessed lower energies than those with extended conformations; turns in the N-terminal region appear are linked to delta receptor affinities. Higher energy conformations derived from the lowest energy clusters illustrated that analogues with extended topographies fit 1-site binding models, while those with multiple turns fitted a 2-site binding model. An hypothesis on opioid peptide conformation suggests differentiation between delta-1 and delta-2 receptor subtypes as well as agonists and antagonists; hydrodrophobic side-chains in position 2, 3 or 4 modulate peptide conformation, and affect affinity and selectivity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES090078-01
Application #
5202290
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Balboni, Gianfranco; Onnis, Valentina; Congiu, Cenzo et al. (2007) Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore. Bioorg Med Chem 15:3143-51
Li, Tingyou; Jinsmaa, Yunden; Nedachi, Masahiro et al. (2007) Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonists. Bioorg Med Chem 15:1237-51
Li, Tingyou; Shiotani, Kimitaka; Miyazaki, Anna et al. (2007) Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands. J Med Chem 50:2753-66
Marczak, Ewa D; Jinsmaa, Yunden; Li, Tingyou et al. (2007) [N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist properties. J Pharmacol Exp Ther 323:374-80
Vazquez, M Eugenio; Blanco, Juan B; Salvadori, Severo et al. (2006) 6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. J Med Chem 49:3653-8
Li, Tingyou; Tsuda, Yuko; Minoura, Katsuhiko et al. (2006) Enantioselective synthesis of a phenylalanine library containing alkyl groups on the aromatic moiety: confirmation of stereostructure by x-ray analysis. Chem Pharm Bull (Tokyo) 54:873-7
Jinsmaa, Yunden; Marczak, Ewa; Fujita, Yoshio et al. (2006) Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1. Pharmacol Biochem Behav 84:252-8
Miyazaki, Anna; Fujisawa, Yutaka; Shiotani, Kimitaka et al. (2005) Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenation. Chem Pharm Bull (Tokyo) 53:1152-8
Li, Tingyou; Fujita, Yoshio; Shiotani, Kimitaka et al. (2005) Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists. J Med Chem 48:8035-44
Balboni, Gianfranco; Guerrini, Remo; Salvadori, Severo et al. (2005) Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1). J Med Chem 48:8112-4

Showing the most recent 10 out of 31 publications